The PDE4 inhibitor roflumilast provides additional clinical benefit in COPD patients treated with tiotropium

Author(s):
Kroker, A.; Gehling, U.; Bethke, T.D.; Gooss, A.; Rabe, K.F.
Published
2010
Publication type
Other
Date issued
2010-04-03
Language
English
hdl
1887/111434